The Global High Intensity Focused Ultrasound Market size is expected to reach $1.9 billion by 2031, rising at a market growth of 7.1% CAGR during the forecast period.
HIFU is a uterus-preserving procedure, which is important for patients who wish to retain their uterus for future pregnancies. This aspect of HIFU makes it a preferred option for women who want to avoid hysterectomy, which involves the removal of the uterus. Thus, the uterine fibroids segment attained 19% revenue share in the market in 2023. HIFU is typically performed as an outpatient, meaning patients do not need to stay overnight in a hospital. This convenience adds to its appeal and makes it a more accessible option for many.
Chronic diseases like cancer are becoming more prevalent worldwide, with increasing rates of prostate cancer, liver cancer, and other solid tumours. HIFU has been established as an effective non-invasive treatment option for certain types of cancer, such as prostate cancer, where it is used to destroy cancerous tissues without the need for surgery. As per the WHO, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths. The most common cancers are breast, lung, colon and rectum and prostate cancers. Hence, the increasing prevalence of chronic diseases drives the market's growth.
Patients increasingly seek less invasive treatments with fewer risks and shorter recovery times. Traditional surgical procedures often involve incisions, anaesthesia, and extended hospital stays, which can be daunting for many patients. In contrast, HIFU offers a non-invasive alternative using focused ultrasound waves to target and treat tissues without incisions. This appeal of a less invasive treatment option drives patient preference toward HIFU, increasing its adoption. In conclusion, the growing preference for non-invasive procedures propels the market's growth.
However, HIFU equipment is sophisticated and technologically advanced, which results in high initial capital costs. The expense of purchasing, installing, and setting up HIFU systems can be prohibitive, particularly for smaller healthcare facilities or those in developing regions. This high upfront investment can deter healthcare providers from adopting HIFU technology. The maintenance of HIFU equipment requires specialized service and regular upgrades to ensure optimal performance. These ongoing costs add to the total expenditure of operating HIFU systems. In conclusion, the high cost of equipment and procedures is hampering the market's growth.
Application Outlook
Based on application, the market is divided into uterine fibroids, prostate cancer, essential tremor, dermatology, breast cancer, glaucoma, back pain, facetogenic, and others. In 2023, the dermatology segment garnered 20% revenue share in the market. HIFU is effective for non-surgical face lifting and tightening, which addresses common dermatological concerns such as sagging skin and wrinkles. It stimulates collagen production, leading to skin tightening and rejuvenation, which is particularly appealing in the cosmetic dermatology market.
End Use Outlook
By end use, the market is divided into hospitals, imaging centers, and others. The imaging centres segment procured 33% revenue share in the market in 2023. Imaging centres specialize in diagnostic imaging and interventional procedures, making them well-suited for performing HIFU. The expertise and focus on imaging in these centres enhance the quality of HIFU treatments and ensure accurate targeting. Imaging centres often provide a more accessible and convenient location for patients than hospitals.
Regional Outlook
Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 38% revenue share in the market in 2023. North America, particularly the United States and Canada, has a well-developed healthcare infrastructure with access to cutting-edge medical technologies and facilities. This infrastructure supports the adoption and use of advanced treatments like HIFU. The prevalence of conditions that HIFU can treat, such as uterine fibroids, prostate cancer, and certain types of tumours, is relatively high in North America. This drives the demand for effective treatment options.
List of Key Companies Profiled
- EDAP TMS S.A
- Sonablate Corp.
- Verasonics, Inc.
- ALPINION MEDICAL SYSTEMS Co., Ltd.
- Theraclion
- Lynton Lasers Ltd
- ULTRAISER
- PROFOUND MEDICAL CORP.
Global High Intensity Focused Ultrasound Market Report Segmentation
By End Use
- Hospital
- Imaging Centers
- Others
By Application
- Dermatology
- Uterine Fibroids
- Prostate Cancer
- Essential Tremor
- Breast Cancer
- Glaucoma
- Backpain, Facetogenic
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Global High Intensity Focused Ultrasound Market, by End Use
- 1.4.2 Global High Intensity Focused Ultrasound Market, by Application
- 1.4.3 Global High Intensity Focused Ultrasound Market, by Geography
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. Global High Intensity Focused Ultrasound Market by End Use
- 4.1 Global Hospital Market by Region
- 4.2 Global Imaging Centers Market by Region
- 4.3 Global Others Market by Region
Chapter 5. Global High Intensity Focused Ultrasound Market by Application
- 5.1 Global Dermatology Market by Region
- 5.2 Global Uterine Fibroids Market by Region
- 5.3 Global Prostate Cancer Market by Region
- 5.4 Global Essential Tremor Market by Region
- 5.5 Global Breast Cancer Market by Region
- 5.6 Global Glaucoma Market by Region
- 5.7 Global Backpain, Facetogenic Market by Region
- 5.8 Global Others Market by Region
Chapter 6. Global High Intensity Focused Ultrasound Market by Region
- 6.1 North America High Intensity Focused Ultrasound Market
- 6.1.1 North America High Intensity Focused Ultrasound Market by End Use
- 6.1.1.1 North America Hospital Market by Country
- 6.1.1.2 North America Imaging Centers Market by Country
- 6.1.1.3 North America Others Market by Country
- 6.1.2 North America High Intensity Focused Ultrasound Market by Application
- 6.1.2.1 North America Dermatology Market by Country
- 6.1.2.2 North America Uterine Fibroids Market by Country
- 6.1.2.3 North America Prostate Cancer Market by Country
- 6.1.2.4 North America Essential Tremor Market by Country
- 6.1.2.5 North America Breast Cancer Market by Country
- 6.1.2.6 North America Glaucoma Market by Country
- 6.1.2.7 North America Backpain, Facetogenic Market by Country
- 6.1.2.8 North America Others Market by Country
- 6.1.3 North America High Intensity Focused Ultrasound Market by Country
- 6.1.3.1 US High Intensity Focused Ultrasound Market
- 6.1.3.1.1 US High Intensity Focused Ultrasound Market by End Use
- 6.1.3.1.2 US High Intensity Focused Ultrasound Market by Application
- 6.1.3.2 Canada High Intensity Focused Ultrasound Market
- 6.1.3.2.1 Canada High Intensity Focused Ultrasound Market by End Use
- 6.1.3.2.2 Canada High Intensity Focused Ultrasound Market by Application
- 6.1.3.3 Mexico High Intensity Focused Ultrasound Market
- 6.1.3.3.1 Mexico High Intensity Focused Ultrasound Market by End Use
- 6.1.3.3.2 Mexico High Intensity Focused Ultrasound Market by Application
- 6.1.3.4 Rest of North America High Intensity Focused Ultrasound Market
- 6.1.3.4.1 Rest of North America High Intensity Focused Ultrasound Market by End Use
- 6.1.3.4.2 Rest of North America High Intensity Focused Ultrasound Market by Application
- 6.2 Europe High Intensity Focused Ultrasound Market
- 6.2.1 Europe High Intensity Focused Ultrasound Market by End Use
- 6.2.1.1 Europe Hospital Market by Country
- 6.2.1.2 Europe Imaging Centers Market by Country
- 6.2.1.3 Europe Others Market by Country
- 6.2.2 Europe High Intensity Focused Ultrasound Market by Application
- 6.2.2.1 Europe Dermatology Market by Country
- 6.2.2.2 Europe Uterine Fibroids Market by Country
- 6.2.2.3 Europe Prostate Cancer Market by Country
- 6.2.2.4 Europe Essential Tremor Market by Country
- 6.2.2.5 Europe Breast Cancer Market by Country
- 6.2.2.6 Europe Glaucoma Market by Country
- 6.2.2.7 Europe Backpain, Facetogenic Market by Country
- 6.2.2.8 Europe Others Market by Country
- 6.2.3 Europe High Intensity Focused Ultrasound Market by Country
- 6.2.3.1 Germany High Intensity Focused Ultrasound Market
- 6.2.3.1.1 Germany High Intensity Focused Ultrasound Market by End Use
- 6.2.3.1.2 Germany High Intensity Focused Ultrasound Market by Application
- 6.2.3.2 UK High Intensity Focused Ultrasound Market
- 6.2.3.2.1 UK High Intensity Focused Ultrasound Market by End Use
- 6.2.3.2.2 UK High Intensity Focused Ultrasound Market by Application
- 6.2.3.3 France High Intensity Focused Ultrasound Market
- 6.2.3.3.1 France High Intensity Focused Ultrasound Market by End Use
- 6.2.3.3.2 France High Intensity Focused Ultrasound Market by Application
- 6.2.3.4 Russia High Intensity Focused Ultrasound Market
- 6.2.3.4.1 Russia High Intensity Focused Ultrasound Market by End Use
- 6.2.3.4.2 Russia High Intensity Focused Ultrasound Market by Application
- 6.2.3.5 Spain High Intensity Focused Ultrasound Market
- 6.2.3.5.1 Spain High Intensity Focused Ultrasound Market by End Use
- 6.2.3.5.2 Spain High Intensity Focused Ultrasound Market by Application
- 6.2.3.6 Italy High Intensity Focused Ultrasound Market
- 6.2.3.6.1 Italy High Intensity Focused Ultrasound Market by End Use
- 6.2.3.6.2 Italy High Intensity Focused Ultrasound Market by Application
- 6.2.3.7 Rest of Europe High Intensity Focused Ultrasound Market
- 6.2.3.7.1 Rest of Europe High Intensity Focused Ultrasound Market by End Use
- 6.2.3.7.2 Rest of Europe High Intensity Focused Ultrasound Market by Application
- 6.3 Asia Pacific High Intensity Focused Ultrasound Market
- 6.3.1 Asia Pacific High Intensity Focused Ultrasound Market by End Use
- 6.3.1.1 Asia Pacific Hospital Market by Country
- 6.3.1.2 Asia Pacific Imaging Centers Market by Country
- 6.3.1.3 Asia Pacific Others Market by Country
- 6.3.2 Asia Pacific High Intensity Focused Ultrasound Market by Application
- 6.3.2.1 Asia Pacific Dermatology Market by Country
- 6.3.2.2 Asia Pacific Uterine Fibroids Market by Country
- 6.3.2.3 Asia Pacific Prostate Cancer Market by Country
- 6.3.2.4 Asia Pacific Essential Tremor Market by Country
- 6.3.2.5 Asia Pacific Breast Cancer Market by Country
- 6.3.2.6 Asia Pacific Glaucoma Market by Country
- 6.3.2.7 Asia Pacific Backpain, Facetogenic Market by Country
- 6.3.2.8 Asia Pacific Others Market by Country
- 6.3.3 Asia Pacific High Intensity Focused Ultrasound Market by Country
- 6.3.3.1 China High Intensity Focused Ultrasound Market
- 6.3.3.1.1 China High Intensity Focused Ultrasound Market by End Use
- 6.3.3.1.2 China High Intensity Focused Ultrasound Market by Application
- 6.3.3.2 Japan High Intensity Focused Ultrasound Market
- 6.3.3.2.1 Japan High Intensity Focused Ultrasound Market by End Use
- 6.3.3.2.2 Japan High Intensity Focused Ultrasound Market by Application
- 6.3.3.3 India High Intensity Focused Ultrasound Market
- 6.3.3.3.1 India High Intensity Focused Ultrasound Market by End Use
- 6.3.3.3.2 India High Intensity Focused Ultrasound Market by Application
- 6.3.3.4 South Korea High Intensity Focused Ultrasound Market
- 6.3.3.4.1 South Korea High Intensity Focused Ultrasound Market by End Use
- 6.3.3.4.2 South Korea High Intensity Focused Ultrasound Market by Application
- 6.3.3.5 Singapore High Intensity Focused Ultrasound Market
- 6.3.3.5.1 Singapore High Intensity Focused Ultrasound Market by End Use
- 6.3.3.5.2 Singapore High Intensity Focused Ultrasound Market by Application
- 6.3.3.6 Australia High Intensity Focused Ultrasound Market
- 6.3.3.6.1 Australia High Intensity Focused Ultrasound Market by End Use
- 6.3.3.6.2 Australia High Intensity Focused Ultrasound Market by Application
- 6.3.3.7 Rest of Asia Pacific High Intensity Focused Ultrasound Market
- 6.3.3.7.1 Rest of Asia Pacific High Intensity Focused Ultrasound Market by End Use
- 6.3.3.7.2 Rest of Asia Pacific High Intensity Focused Ultrasound Market by Application
- 6.4 LAMEA High Intensity Focused Ultrasound Market
- 6.4.1 LAMEA High Intensity Focused Ultrasound Market by End Use
- 6.4.1.1 LAMEA Hospital Market by Country
- 6.4.1.2 LAMEA Imaging Centers Market by Country
- 6.4.1.3 LAMEA Others Market by Country
- 6.4.2 LAMEA High Intensity Focused Ultrasound Market by Application
- 6.4.2.1 LAMEA Dermatology Market by Country
- 6.4.2.2 LAMEA Uterine Fibroids Market by Country
- 6.4.2.3 LAMEA Prostate Cancer Market by Country
- 6.4.2.4 LAMEA Essential Tremor Market by Country
- 6.4.2.5 LAMEA Breast Cancer Market by Country
- 6.4.2.6 LAMEA Glaucoma Market by Country
- 6.4.2.7 LAMEA Backpain, Facetogenic Market by Country
- 6.4.2.8 LAMEA Others Market by Country
- 6.4.3 LAMEA High Intensity Focused Ultrasound Market by Country
- 6.4.3.1 Brazil High Intensity Focused Ultrasound Market
- 6.4.3.1.1 Brazil High Intensity Focused Ultrasound Market by End Use
- 6.4.3.1.2 Brazil High Intensity Focused Ultrasound Market by Application
- 6.4.3.2 Argentina High Intensity Focused Ultrasound Market
- 6.4.3.2.1 Argentina High Intensity Focused Ultrasound Market by End Use
- 6.4.3.2.2 Argentina High Intensity Focused Ultrasound Market by Application
- 6.4.3.3 UAE High Intensity Focused Ultrasound Market
- 6.4.3.3.1 UAE High Intensity Focused Ultrasound Market by End Use
- 6.4.3.3.2 UAE High Intensity Focused Ultrasound Market by Application
- 6.4.3.4 Saudi Arabia High Intensity Focused Ultrasound Market
- 6.4.3.4.1 Saudi Arabia High Intensity Focused Ultrasound Market by End Use
- 6.4.3.4.2 Saudi Arabia High Intensity Focused Ultrasound Market by Application
- 6.4.3.5 South Africa High Intensity Focused Ultrasound Market
- 6.4.3.5.1 South Africa High Intensity Focused Ultrasound Market by End Use
- 6.4.3.5.2 South Africa High Intensity Focused Ultrasound Market by Application
- 6.4.3.6 Nigeria High Intensity Focused Ultrasound Market
- 6.4.3.6.1 Nigeria High Intensity Focused Ultrasound Market by End Use
- 6.4.3.6.2 Nigeria High Intensity Focused Ultrasound Market by Application
- 6.4.3.7 Rest of LAMEA High Intensity Focused Ultrasound Market
- 6.4.3.7.1 Rest of LAMEA High Intensity Focused Ultrasound Market by End Use
- 6.4.3.7.2 Rest of LAMEA High Intensity Focused Ultrasound Market by Application
Chapter 7. Company Profiles
- 7.1 EDAP TMS S.A
- 7.1.1 Company Overview
- 7.1.2 Financial Analysis
- 7.1.3 Segmental and Regional Analysis
- 7.1.4 Research & Development Expenses
- 7.2 Sonablate Corp.
- 7.3 Verasonics, Inc.
- 7.4 ALPINION MEDICAL SYSTEMS Co., Ltd.
- 7.5 Theraclion
- 7.6 Lynton Lasers Ltd
- 7.7 ULTRAISER
- 7.8 Profound Medical Corp.
- 7.8.1 Company Overview
- 7.8.2 Financial Analysis
Chapter 8. Winning Imperatives for High Intensity Focused Ultrasound Market